Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
The author(s) reported there is no funding associated with the work featured in this article.
Leukemia & Lymphoma
Volume 63, 2022 - Issue 5
Letters to the Editor
A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia
Andrea Messoria HTA Unit, Regional Health Service, Firenze, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-5829-107XView further author information
https://orcid.org/0000-0002-5829-107XView further author information, Melania Rivanob Clinical Oncology Pharmacy Department, A. Businco Hospital, Cagliari, Italyhttps://orcid.org/0000-0002-8541-539XView further author information
https://orcid.org/0000-0002-8541-539XView further author information, Daniele Mengatoc Hospital Pharmacy Department, Azienda Ulss Padova, Padova, Italyhttps://orcid.org/0000-0003-1374-1505View further author information
https://orcid.org/0000-0003-1374-1505View further author information, Luca Cancanellid Hospital Pharmacy Department, Azienda Ulss 2 Marca Trevigiana, Treviso, Italyhttps://orcid.org/0000-0002-6409-4195View further author information
https://orcid.org/0000-0002-6409-4195View further author information, Lorenzo Di Spazioe Hospital Pharmacy Department, S. Chiara Hospital, Trento, Italyhttps://orcid.org/0000-0002-1048-5166View further author information
https://orcid.org/0000-0002-1048-5166View further author information & Marco Chiumentef Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italyhttps://orcid.org/0000-0002-0943-6746View further author information
https://orcid.org/0000-0002-0943-6746View further author information![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})